Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SPRC vs CDT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CDT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–2 Matrix Metrics)

CDT Overall Winner 6-Pillar Tally: SPRC 2 – 3 CDT (1 Tie) Matrix Metrics: SPRC 2 – 4 CDT

As of Nov 20, 2026, CDT Equity Inc. (CDT) is the stronger overall head-to-head candidate over SciSparc Ltd. (SPRC) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SPRC carries a Unified Composite Score of 44.2/100 (HOLD) at $0.20 (N/M Forward P/E, -725.2% operating margin), whereas CDT carries 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While SPRC currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. CDT 31.6/100 SELL), CDT captures the overall institutional head-to-head verdict (4–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -725.2% operating margin) and revenue trajectory (+0.0% vs. -38.4% YoY).
  • Technical & Structure Timing Caution: SPRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 14.5); meanwhile CDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SPRC vs CDT
SPRC NASDAQ
SciSparc Ltd. Ordinary Shares
Retail-Auto Dealers & Gasoline Stations
$0.20
-34.83% 1D
Market Cap $739,034
TTM Revenue $679,000
Forward P/E N/M
Beta / 30D Vol 0.93β · 205% Vol
Unified Composite Score
44.2 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -47.0%), weak momentum, RSI 14
RSI-14: 14.5 · SMA20: $0.51 · SMA50: $2.52
CDT NASDAQ Head-to-Head Winner
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -17.75β · 10175% Vol
Unified Composite Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -58.9%), weak momentum, RSI 44
RSI-14: 44.1 · SMA20: $0.31 · SMA50: $0.40

6-Pillar Scorecard Institutional Category Breakdown (SPRC 2 – 3 CDT)

Columns: Metric · SPRC · CDT
1. Valuation Multiples SPRC
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 1.1x N/M
2. Growth & Scale CDT
Revenue Growth (YoY) -38.4% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $679,000 N/A
Market Cap $739,034 $507,528
3. Profitability & Quality CDT
Gross Margin N/A N/A
Operating Margin -725.2% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -164.5% -69.7%
4. Balance Sheet & Cash Flow CDT
Cash Generation (TTM) -$4.8M EBITDA N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $6.79 Book/Sh · -164.5% ROE $435,000 Net Debt (0.01x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SPRC
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SPRC (2) vs CDT (4)
Institutional Metric SPRC CDT Criterion Row Edge
Market Capitalization
Scale
$739,034 $507,528 Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-38.4% +0.0% Higher Growth CDT
Operating Margin (TTM)
Profitability
-725.2% 0.0% Higher Margin CDT
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-164.5% -69.7% Higher ROE CDT
52-Week Range Position
Momentum
0% ($0–$16) 2% ($0–$11) Stronger Trend CDT
Beta / 30D Volatility
Risk Regime
0.93β · 205% Vol -17.75β · 10175% Vol Lower Realized Risk SPRC
Unified Institutional Score
Composite Signal
44.2 / 100 (HOLD) 31.6 / 100 (SELL) Higher Composite SPRC
Trailing 12M Revenue (USD)
Operating Scale
$679,000 N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.8M EBITDA ($6.79 Book/Sh · -164.5% ROE) N/A ($435,000 Net Debt (0.01x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CDT +160.5 pp
SPRC: -83.71% · CDT: +76.79%
3M Horizon CDT +6.3 pp
SPRC: -97.06% · CDT: -90.76%
6M Horizon CDT +17.32 pp
SPRC: -95.42% · CDT: -78.1%
1Y Horizon CDT +5.27 pp
SPRC: -92.05% · CDT: -86.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SPRC vs CDT. Trailing 12-month operating profitability (SPRC -725.2% vs CDT 0.0%) and valuation multiples (SPRC N/M vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SPRC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$679,000
Gross MarginN/A
Op. Margin-725.2%
ROE / Fwd P/E-164.5% · N/M
CDT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-69.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SPRC BREAKDOWN
117d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact SPRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CDT BREAKDOWN
163d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SPRC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $739,034 market capitalization and -725.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CDT Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $507,528 market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SPRC vs CDT Key Questions & Quantitative Answers

As of Nov 20, 2026, CDT Equity Inc. (CDT) is the stronger overall head-to-head candidate over SciSparc Ltd. (SPRC) in the Tradestie Institutional Equity Comparison Engine, winning 4–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SPRC carries a Unified Composite Score of 44.2/100 (HOLD) at $0.20 (N/M Forward P/E, -725.2% operating margin), whereas CDT carries 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While SPRC currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. CDT 31.6/100 SELL), CDT captures the overall institutional head-to-head verdict (4–2 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -725.2% operating margin) and revenue trajectory (+0.0% vs. -38.4% YoY). Technical & Structure Timing Caution: SPRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 14.5); meanwhile CDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CDT leads the Growth & Scale pillar: SPRC posts -38.4% YoY revenue growth and +0.0% YoY earnings growth on $679,000 TTM revenue (N/A gross margin, -725.2% operating margin), compared with CDT at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, SPRC generates $679,000 in USD-normalized revenue versus N/A for CDT. In operating R&D and SG&A reinvestment, SPRC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CDT.

SPRC screens cheaper on headline valuation multiples. SPRC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.1x EV/Revenue (unreported EBITDA margin), whereas CDT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SPRC (-164.5% ROE) versus CDT (-69.7% ROE) capital efficiency.

In options market volatility and institutional positioning, SPRC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 205% Vol realized risk). By comparison, CDT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-17.75β · 10175% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.